Astonea Labs Ltd has completed the sale of two commercial units located in Gurugram for a total consideration of Rs 2.99 crore. The transaction, finalized on July 17, 2026, involves the monetization of immovable assets to optimize the company's portfolio and strengthen its financial position. The sale was executed and registered via a Sale Deed, with the consideration received as per the agreement terms.

The properties sold include Commercial Units bearing Nos. FF-508 and FF-509, situated on the 5th Floor of JMD Megapolis on Sohna Road, Sector 48, Gurugram. Each unit admeasures 1,361 sq. ft. The units were jointly purchased by Mr. Suresh Kumar Satija and Mrs. Santosh Satija. The company confirmed that the transaction is not a related party transaction and that no promoters or group companies hold any interest in the deal.

Transaction Details

The disclosure was made to BSE Limited in compliance with Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company stated that the sale is not expected to have any material adverse impact on its business operations.

The company intends to utilize the proceeds to further its objective of asset portfolio optimization.

Astonea Labs has received a certificate from the Supreme Board of Drugs and Medical Appliances (SBDMA), Ministry of Health and Population, Republic of Yemen, confirming the successful inspection of its manufacturing facility. The inspection was conducted at the company's plant located in Village Haripur, Tehsil Raipur Rani, Panchkula, Haryana. The receipt of the certificate on July 14, 2026, validates the facility's compliance with the standards required by the Yemeni regulatory authority.

The intimation was submitted to BSE Limited pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure confirms that the inspection process has been formally concluded with a positive outcome.

Inspection Details

The regulatory audit focused on the manufacturing capabilities and quality standards of the facility situated in Haryana. The successful completion and subsequent certification allow the company to maintain its operational alignment with the requirements of the SBDMA.